201 related articles for article (PubMed ID: 25641192)
1. Anti-thyroid and antifungal activities, BSA interaction and acid phosphatase inhibition of methimazole copper(II) complexes.
Urquiza NM; Islas MS; Ariza ST; Jori N; Martínez Medina JJ; Lavecchia MJ; López Tévez LL; Lezama L; Rojo T; Williams PA; Ferrer EG
Chem Biol Interact; 2015 Mar; 229():64-72. PubMed ID: 25641192
[TBL] [Abstract][Full Text] [Related]
2. Copper(II) complexes of methimazole, an anti Grave's disease drug. Synthesis, characterization and its potential biological behavior as alkaline phosphatase inhibitor.
Urquiza NM; Manca SG; Moyano MA; Dellmans RA; Lezama L; Rojo T; Naso LG; Williams PA; Ferrer EG
Biometals; 2010 Apr; 23(2):255-64. PubMed ID: 20012553
[TBL] [Abstract][Full Text] [Related]
3. In vitro DNA and BSA-binding, cell imaging and anticancer activity against human carcinoma cell lines of mixed ligand copper(II) complexes.
Anjomshoa M; Torkzadeh-Mahani M
Spectrochim Acta A Mol Biomol Spectrosc; 2015; 150():390-402. PubMed ID: 26057093
[TBL] [Abstract][Full Text] [Related]
4. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
[TBL] [Abstract][Full Text] [Related]
5. Cu(II) complexes with co-planar [Cu(II)(N-N)(HIMC⁻)], their anti-cancer activities, ΔG, ΔE and solid luminescence.
Cheng YF; Lu XM; Wang G
Dalton Trans; 2014 Apr; 43(14):5357-63. PubMed ID: 24519174
[TBL] [Abstract][Full Text] [Related]
6. Mixed ligand μ-phenoxo-bridged dinuclear copper(II) complexes with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
Loganathan R; Ramakrishnan S; Suresh E; Palaniandavar M; Riyasdeen A; Akbarsha MA
Dalton Trans; 2014 Apr; 43(16):6177-94. PubMed ID: 24595529
[TBL] [Abstract][Full Text] [Related]
7. Copper(II) complexes with the non-steroidal anti-inflammatory drug tolfenamic acid: Structure and biological features.
Tarushi A; Perontsis S; Hatzidimitriou AG; Papadopoulos AN; Kessissoglou DP; Psomas G
J Inorg Biochem; 2015 Aug; 149():68-79. PubMed ID: 25824465
[TBL] [Abstract][Full Text] [Related]
8. Ternary copper(II)-polypyridyl enantiomers: aldol-type condensation, characterization, DNA-binding recognition, BSA-binding and anticancer property.
Ng CH; Wang WS; Chong KV; Win YF; Neo KE; Lee HB; San SL; Raja Abd Rahman RN; Leong WK
Dalton Trans; 2013 Jul; 42(28):10233-43. PubMed ID: 23728518
[TBL] [Abstract][Full Text] [Related]
9. Copper(I) and nickel(II) complexes with 1:1 vs. 1:2 coordination of ferrocenyl hydrazone ligands: do the geometry and composition of complexes affect DNA binding/cleavage, protein binding, antioxidant and cytotoxic activities?
Krishnamoorthy P; Sathyadevi P; Butorac RR; Cowley AH; Bhuvanesh NS; Dharmaraj N
Dalton Trans; 2012 Apr; 41(15):4423-36. PubMed ID: 22344370
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, biological activity, DNA and BSA binding study: novel copper(ii) complexes with 2-hydroxy-4-aryl-4-oxo-2-butenoate.
Joksimović N; Baskić D; Popović S; Zarić M; Kosanić M; Ranković B; Stanojković T; Novaković SB; Davidović G; Bugarčić Z; Janković N
Dalton Trans; 2016 Sep; 45(38):15067-15077. PubMed ID: 27711668
[TBL] [Abstract][Full Text] [Related]
11. Targeted water soluble copper-tetrazolate complexes: interactions with biomolecules and catecholase like activities.
Saha M; Das M; Nasani R; Choudhuri I; Yousufuddin M; Nayek HP; Shaikh MM; Pathak B; Mukhopadhyay S
Dalton Trans; 2015 Dec; 44(46):20154-67. PubMed ID: 26530012
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structural characterization and cytotoxic activity of ternary copper(II)-dipeptide-phenanthroline complexes. A step towards the development of new copper compounds for the treatment of cancer.
Iglesias S; Alvarez N; Torre MH; Kremer E; Ellena J; Ribeiro RR; Barroso RP; Costa-Filho AJ; Kramer MG; Facchin G
J Inorg Biochem; 2014 Oct; 139():117-23. PubMed ID: 25033418
[TBL] [Abstract][Full Text] [Related]
13. In vitro cytotoxic activities, DNA-, and BSA-binding studies of a new dinuclear copper(II) complex with N-[3-(dimethylamino)propyl]-N'-(2-carboxylatophenyl)-oxamide as ligand.
Jiao J; Jiang M; Li YT; Wu ZY; Yan CW
J Biochem Mol Toxicol; 2014 Feb; 28(2):47-59. PubMed ID: 24497175
[TBL] [Abstract][Full Text] [Related]
14. Tailoring copper(ii) complexes with pyridine-4,5-dicarboxylate esters for anti-Candida activity.
Andrejević TP; Aleksic I; Počkaj M; Kljun J; Milivojevic D; Stevanović NL; Nikodinovic-Runic J; Turel I; Djuran MI; Glišić BĐ
Dalton Trans; 2021 Feb; 50(7):2627-2638. PubMed ID: 33523054
[TBL] [Abstract][Full Text] [Related]
15. Antifungal promising agents of zinc(II) and copper(II) derivatives based on azole drug.
de Azevedo-França JA; Borba-Santos LP; de Almeida Pimentel G; Franco CHJ; Souza C; de Almeida Celestino J; de Menezes EF; Dos Santos NP; Vieira EG; Ferreira AMDC; de Souza W; Rozental S; Navarro M
J Inorg Biochem; 2021 Jun; 219():111401. PubMed ID: 33756392
[TBL] [Abstract][Full Text] [Related]
16. Copper(II) complexes with antimicrobial drug flumequine: structure and biological evaluation.
Chalkidou E; Perdih F; Turel I; Kessissoglou DP; Psomas G
J Inorg Biochem; 2012 Aug; 113():55-65. PubMed ID: 22694822
[TBL] [Abstract][Full Text] [Related]
17. Copper Complexes with 1,10-Phenanthroline Derivatives: Underlying Factors Affecting Their Cytotoxicity.
Nunes P; Correia I; Marques F; Matos AP; Dos Santos MMC; Azevedo CG; Capelo JL; Santos HM; Gama S; Pinheiro T; Cavaco I; Pessoa JC
Inorg Chem; 2020 Jul; 59(13):9116-9134. PubMed ID: 32578983
[TBL] [Abstract][Full Text] [Related]
18. Calorimetric and spectroscopic studies on the interaction of methimazole with bovine serum albumin.
Singh SK; Kishore N
J Pharm Sci; 2008 Jun; 97(6):2362-72. PubMed ID: 17879290
[TBL] [Abstract][Full Text] [Related]
19. Potential bio-protective effect of copper compounds: mimicking SOD and peroxidases enzymes and inhibiting acid phosphatase as a target for anti-osteoporotic chemotherapeutics.
Martini N; Parente JE; D Alessandro F; Rey M; Rizzi A; Williams PAM; Ferrer EG
Mol Biol Rep; 2019 Feb; 46(1):867-885. PubMed ID: 30506507
[TBL] [Abstract][Full Text] [Related]
20. Interaction of copper(II) with the non-steroidal anti-inflammatory drugs naproxen and diclofenac: synthesis, structure, DNA- and albumin-binding.
Dimiza F; Perdih F; Tangoulis V; Turel I; Kessissoglou DP; Psomas G
J Inorg Biochem; 2011 Mar; 105(3):476-89. PubMed ID: 20926136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
